Twenty-one adult patients with urinary tract infections caused by penicillinresistant bacteria completed treatment with amoxicillin alone or amoxicillin plus clavulanic acid in a randomized double-blind clinical trial. Of the 13 patients treated with amoxicilhin plus clavulanic acid, the absence of bacteriuria within 7 days of therapy was observed in 85%, as compared with only 25% of the 8 patients receiving amoxicillin only. There were no significant side effects nor any clinical, biochemical, or hematological abnormalities related to either treatment. It was concluded that the combination of clavulanic acid and amoxicillin could be useful in the treatment of uncomplicated urinary tract infection caused by penicillinresistant bacteria.
Clavulanic acid, a natural product of Streptomyces clavuligerus, is a potent, irreversible inhibitor of a wide variety of 8-lactamase enzymes (5, 7) . Although it has little inherent antibacterial activity, it protects the labile penicillins and cephalosporins from destruction by bacterial , 8- lactamase (4, 6, 8, 9, 13) . In vitro studies have demonstrated that clavulanic acid possesses a very wide spectrum of inhibition (3) , which results in marked enhancement of,-lactam antibiotics against many 8-lactamase-producing organisms (3, 9, 13) found to have infecting strains with amoxicillin MICs above 10 ug/ml were considered for enrollment in the study. In addition, a further MIC of amoxicilhin was obtained in the presence of 10 ug of clavulanic acid per ml. This concentration of clavulanic acid has been shown to be readily obtainable in the urine after oral administration in humans (unpublished data). Patients with known hypersensitivity to penicillins, pregnancy, liver or renal failure, or who presented with life-threatening infections were excluded from this study. In addition to a pretreatment history and physical examination, all of the patients underwent a laboratory evaluation, including complete blood count; urinalysis; blood urea nitrogen and serum creatinine, bilirubin, alkaline phosphatase, glutamic pyruvic, and oxalacetic transaminases tests. The physical examination and laboratory evaluation were repeated at the completion of therapy. Urine cultures were repeated on days 3 and 6 of treatment and within 7 days of completion of therapy.
Patients were then assigned, by a previously prepared random-number code, to one of two treatments. One group, consisting of eight patients, received amoxicillin alone as a 250-mg tablet. Of the eight patients, four were male, and four were female. Their mean age was 47.6 years. Three were symptomatic, and five were asymptomatic. The other group consisting of 13 patients, was treated with a 250-mg amoxicillin tablet containing either 50 or 125 mg of clavulanic acid. Of the 13 patients, 6 were male, and 7 were female. Their mean age was 46.8 years. Seven were symptomatic, and six were asymptomatic. All medication was given three times a day for 9 days. The trial was completely double blind as the tablets and containers were identical in appearance, and the patients were assigned to each treatment sequentially as they entered the trial. The patients received no other antimicrobial agent during the study. Therapy was discontinued when a urine culture remained positive on either of the two evaluations during treatment.
RESULTS
A total of 21 patients were studied, with 8 receiving amoxicillin alone and the other 13 receiving amoxicillin plus clavulanic acid. The infectious flora with their MICs for amoxicillin plus clavulanic acid, as well as the therapeutic results, are presented in Table 1 . The MICs for amoxicillin alone were greater than 160 ,tg/ml for all isolates. It can be seen that the presence of clavulanic acid at 10 Ag/ml resulted in a decrease in the MICs for amoxicillin against all of the isolated bacteria. In the 13 cases treated with the combination of amoxicillin and clavulanic acid, a total of 11 (84.6%) had negative cultures after completion of therapy, whereas in patients treated with only amoxicillin, 2 (25%) had a negative culture (this difference was sta- tistically significant, P < 0.05). In the patients with therapeutic failure, the original bacteria persisted in the urine. The smal number of cases did not allow an evaluation of a dose-response relationship between patients taking 150 or 375 mg of clavulanic acid per day.
Medication was well tolerated in all 21 patients. Two patients who used amoxicillin plus clavulanic acid complained of mild nausea, which did not require discontinuation of therapy. No clinical, biochemical, or hematological abnormalities were detected during or after administration of the two treatments in any patient.
DISCUSSION
Urinary tract infections by fl-lactamase-producing species are frequent. In our experience of 284 consecutive bacterial isolates from patients with urinary tract infections, 36% (102 isolates) were resistant to ampicillin or amoxicillin (unpublished data). In view of the significant number of infections by penicillin-resistant species, the combination of amoxicillin with clavulanic acid could be a valuable therapy. In this preliminary study the combination of amoxicillin and clavulanic acid was associated with a negative posttreatment culture in 85% of cases (11 or 13 patients), as compared with only 25% of patients receiving amoxicillin alone (2 or 8 patients). This difference was statistically significant (P < 0.05). These data are very similar to another study of urinary tract infection due to ampicillin-resistant bacteria, where 67% of patients had negative urine cultures after amoxicillin plus clavulanic acid, whereas only 27% were negative with amoxicillin alone (10) .
The fact that two patients showed a negative culture after amoxicillin therapy, even though the isolate was resistant in vitro to amoxicillin, should not be surprising. It is known that spontaneous disappearance of bacteriuria can occur in urinary tract infections, especially in those of the lower tract. Antibiotic levels attained in the urine may be much greater then the concentration in the disk, and discrepancy between in vitro susceptibility testing and in vivo response may occur (11) . of clavulanic acid and amoxicillin were considered excellent in this preliminary trial with only mild nausea seen in two cases. Obviously this initial limited therapeutic trial must be extended to a larger group of patients and include longterm follow-up evaluations before a definite conclusion can be drawn. However, it appears that an association of amoxicillin and clavulanic acid may be useful in the treatment of urinary tract infections caused by penicillin-resistant bacteria.
